About Propound Pharma Consulting Private Limited
Data last updated:
Propound Pharma Consulting Private Limited is a private limited company based in Bangalore, Karnataka, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 29 June 2015.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2015PTC081212. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Poornima Mokshagundam and Prathima Sundhar.
Its last annual general meeting (AGM) was held on 08 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No 167 4th Main Road Judicial Layoutthalaghattapura, Bangalore, Karnataka, India – 560062.
As per the financials filed for FY 2025, the company reported a revenue of ₹12,480, a decline of 100% compared to the previous year. For the same year it recorded a net loss of ₹3.53 Lakh and EBITDA of -₹3.53 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 80% over three years and 23% over five years.
The company is associated with 1 brand: Propound Pharma.
The last known website on record is propoundpharma.com.
Company details
Contact details
Propound Pharma Consulting Private Limited's registered office is in Bangalore, Karnataka. Its website is propoundpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo 167 4th Main Road Judicial Layoutthalaghattapura, Bangalore, Karnataka, India – 560062
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Propound Pharma Consulting Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Propound Pharma Consulting operates one associated brand: Propound Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Consulting services for pharmaceutical and biotech facility design, operations assessment, and regulatory compliance. | propoundpharma.com |
Financials of Propound Pharma Consulting Private Limited
FY 2025 filings availablePropound Pharma Consulting Private Limited reported revenue of ₹12,480 (down 100% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 23% over five years. EBITDA fell 184% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Propound Pharma Consulting Private Limited, buy the company report.
Board of directors of Propound Pharma Consulting Private Limited
Propound Pharma Consulting has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poornima Mokshagundam | Director | 29 Jun 2015 | 11 Years 3 Months | Current |
| Prathima Sundhar | Director | 29 Jun 2015 | 11 Years 3 Months | Current |
Peer comparison
Propound Pharma Consulting Private Limited is compared with the 10 companies closest to it by revenue in the Outsourcing industry (Consulting Services), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shivkrishna Dealtrade Private Limited | ₹12,500 (FY 2021) | -7.0% | Kolkata, West Bengal, India | |||
| Maicss Consultancy Private Limited | ₹12,500 (FY 2023) | New Delhi, Delhi, India | ||||
| Parthsarthi Dealtrade Private Limited | ₹12,500 (FY 2021) | 14.0% | Kolkata, West Bengal, India | |||
| Arbasia Business Alliance Private Limited | ₹12,500 (FY 2025) | Delhi, India | ||||
| S S Business Consulting Services Private Limited | ₹12,488 (FY 2025) | -88.0% | Delhi, India | |||
| Propound Pharma Consulting Private Limitedthis company | ₹12,480 (FY 2025) | -₹3.53 Lakh | -100.0% | Bangalore, Karnataka, India | ||
| India Growth Partners Private Limited | ₹12,454 (FY 2024) | -99.0% | Mumbai, Maharashtra, India | |||
| Ramjay Impex Private Limited | ₹12,436 (FY 2024) | -84.0% | Bangalore, Karnataka, India | |||
| Altoo Research Private Limited | ₹12,436 (FY 2021) | -98.0% | Gurugram, Haryana, India | |||
| Eclend Fintech Private Limited | ₹12,434 (FY 2024) | -5.0% | Chennai, Tamil Nadu, India | |||
| Prime Broking and Trading (OPC) Private Limited | ₹12,390 (FY 2022) | 176.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Propound Pharma Consulting Private Limited, buy the company report.
Auditor
Propound Pharma Consulting Private Limited is audited by SESHADRI & RANGA RAO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SESHADRI & RANGA RAO | FY 2020 | 003717S |
Shareholding
The shareholding of Propound Pharma Consulting Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Propound Pharma Consulting Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Propound Pharma Consulting Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Propound Pharma Consulting Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Propound Pharma Consulting has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Propound Pharma Consulting Private Limited, buy the company report.
Recent activity
Propound Pharma Consulting Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Mokshagundam Pradeep ceased to be Additional Director on 07 Apr 2022.
Frequently asked questions
Propound Pharma Consulting is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Propound Pharma Consulting is a company pending strike off, currently registered as a private limited company based in Bangalore, Karnataka, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 29 June 2015 and is registered under CIN U24230KA2015PTC081212. The company may be struck off soon - caution is advised.
The compliance status of Propound Pharma Consulting is compliant as of 02 September 2026.
Propound Pharma Consulting has 2 current directors:
- Poornima Mokshagundam - Director
- Prathima Sundhar - Director
The CIN (Corporate Identification Number) of Propound Pharma Consulting is U24230KA2015PTC081212. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Propound Pharma Consulting was incorporated on 29 June 2015. It is registered with the Registrar of Companies, Bangalore.
Propound Pharma Consulting can be reached through the website propoundpharma.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Propound Pharma Consulting is at No 167 4th Main Road Judicial Layoutthalaghattapura, Bangalore, Karnataka, India – 560062.
The latest financial statements of Propound Pharma Consulting on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 08 August 2025. Year-wise statements from FY 2016 are in the company report.
No. Propound Pharma Consulting has 1 GST registration on record and it is cancelled or inactive.
Propound Pharma Consulting operates in the business outsourcing industry, in the business and IT consulting segment.